Clinical trial · Interventional
Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.
NCT00377845CI-TRIAL-00001369completedEarly Phase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to compare suitability, specificity and sensitivity of the routine smear and the tampon self-test women perform at home. Study hypothesis: The tampon self-test correspond to the routine cervical smear.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Uterine Cervical Dysplasia | Cervical Intraepithelial Neoplasia | ALIAS | 0.90 |
| Uterine Cervical Neoplasms | Cervical Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Regular Tampax used in 3 hours | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Sensitivity and specificity of the tampon self-test
Secondary outcomes (1)
- measure
- The womens socio-demographic relations according to accept the tampon self-test
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 23 Years
Show eligibility criteria text
Inclusion Criteria: 1. Women with cervical dysplasia been referred to conisation or 2. Women invited to cervical screening program Exclusion Criteria: 1. Women not performing the tampon self-test before conisation or 2. Women not performing the tampon self-test af least 1 month after receiving the tampon
References
Publications (0)
Data not yet available
No reference posted for this study.